statistiche ricercatore

CANDUCCI, FILIPPO

Distribuzione geografica

Continente	#
NA - Nord America	5.667
EU - Europa	2.960
AS - Asia	1.456
SA - Sud America	103
AF - Africa	10
Continente sconosciuto - Info sul continente non disponibili	9
OC - Oceania	4
Totale	10.209

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	5.550
IT - Italia	1.660
UA - Ucraina	503
SG - Singapore	478
TR - Turchia	315
SE - Svezia	248
VN - Vietnam	210
CN - Cina	202
HK - Hong Kong	190
FI - Finlandia	130
DE - Germania	109
CA - Canada	106
IE - Irlanda	92
BR - Brasile	84
GB - Regno Unito	80
RU - Federazione Russa	62
FR - Francia	32
JP - Giappone	24
IN - India	19
MX - Messico	10
AR - Argentina	9
BE - Belgio	9
ES - Italia	9
EU - Europa	9
PL - Polonia	8
NL - Olanda	7
ZA - Sudafrica	7
AT - Austria	5
EC - Ecuador	5
ID - Indonesia	5
LT - Lituania	4
BD - Bangladesh	3
AU - Australia	2
IL - Israele	2
IQ - Iraq	2
NZ - Nuova Zelanda	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
BH - Bahrain	1
BY - Bielorussia	1
CL - Cile	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
EG - Egitto	1
GY - Guiana	1
KW - Kuwait	1
MA - Marocco	1
PE - Perù	1
PK - Pakistan	1
SY - Repubblica araba siriana	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
Totale	10.209

Salva come PNG Salva come JPEG

Città	#
Milan	1.279
Fairfield	841
Woodbridge	508
Ashburn	442
Jacksonville	429
Houston	387
Chandler	350
Ann Arbor	313
Seattle	302
Cambridge	298
Wilmington	275
Singapore	255
Hong Kong	188
Nyköping	163
Princeton	144
Izmir	141
Dearborn	137
Dallas	129
Boardman	113
Toronto	95
Dong Ket	93
Dublin	89
Rome	70
The Dalles	65
Beijing	56
Como	54
San Diego	46
Tokyo	23
Chicago	21
London	20
Los Angeles	20
Ogden	20
Nanjing	19
Santa Clara	18
New York	17
Kunming	16
Hefei	15
Ho Chi Minh City	13
Hanoi	12
Atlanta	11
São Paulo	11
Brussels	9
Munich	9
Washington	9
Columbus	8
Council Bluffs	8
Denver	8
Verona	8
Warsaw	8
Chengdu	7
Chennai	7
Jinan	7
Mexico City	7
Montreal	7
Norwalk	7
Brooklyn	6
Nanchang	6
Ponte Lambro	6
Guangzhou	5
Hounslow	5
Johannesburg	5
Mumbai	5
Orem	5
Phoenix	5
Poplar	5
Kilburn	4
Redmond	4
Salt Lake City	4
Wuhan	4
Fuzhou	3
Guayaquil	3
Haiphong	3
Helsinki	3
Huzhou	3
Nuremberg	3
Redwood City	3
Rio de Janeiro	3
San Francisco	3
Secaucus	3
Tübingen	3
Vienna	3
Amsterdam	2
Anápolis	2
Aparecida de Goiânia	2
Auckland	2
Baotou	2
Belo Horizonte	2
Boston	2
Cagliari	2
Campo Grande	2
Curitiba	2
Düsseldorf	2
Frankfurt am Main	2
Gallarate	2
Joinville	2
Lanús	2
Mannheim	2
Monserrato	2
Ningbo	2
Quito	2
Totale	7.750

Salva come PNG Salva come JPEG

Nome	#
Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation	204
Duodenal mucosa of patients with type 1 diabetes shows distinctive inflammatory profile and microbiota	194
The Microbiome of the Prostate Tumor Microenvironment	192
One drug for two targets: Biological evaluation of antiretroviral agents endowed with antiproliferative activity	190
Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients.	183
Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules	182
Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation	181
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques.	180
Coronaviridae and SARS-associated coronavirus strain HSR1.	174
Cross-reacting antibacterial auto-antibodies are produced within coronary atherosclerotic plaques of acute coronary syndrome patients.	173
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates.	167
Virological rebound in human immunodeficiency virus-infected patients with or without residual viraemia: results from an extended follow-up	166
Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies.	166
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site.	165
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.	165
Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL-authors' response	164
Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.	163
The interplay of extracellular matrix and microbiome in urothelial bladder cancer	162
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.	161
Helicobacter pylori treatment: a role for probiotics?	157
2-aminothiazolones as anti-HIV agents which act as gp120-CD4 Inhibitors	156
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding	156
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).	156
Epidemiological, molecular and clinical features of enterovirus 109 infection in children and in adult stem cell transplant recipients.	155
Efficacy of a multistep strategy for Helicobacter pylori eradication.	155
Integrase and fusion inhibitors transmitted drug resistance in naive patients with recent diagnosis of HIV-1 infection.	155
Immunological recovery after 24 weeks of antiretroviral therapy in patients with x4 virus during primary hiv infection	154
Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient.	149
Onset of Berger disease after Staphylococcus aureus infection: septic arthritis after anterior cruciate ligament reconstruction.	147
Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir.	147
Oral probiotic VSL#3 prevents autoimmune diabetes by modulating microbiota and promoting indoleamine 2,3-dioxygenase-enriched tolerogenic intestinal environment	146
GB virus C and survival in persons with HIV infection	145
Pregnancy and H1N1 infection.	144
Probiotics and Helicobacter pylori eradication.	143
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption.	142
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction.	141
Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience.	140
Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients.	139
Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjects.	139
Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein.	139
The role of infections and coinfections with newly identified and emerging respiratory viruses in children.	138
Molecular epidemiology of KI and WU polyomaviruses in infants with acute respiratory disease and in adult hematopoietic stem cell transplant recipients.	138
HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients.	138
Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease.	137
Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir.	136
Evolutionary characteristics of HIV type 1 variants resistant to protease inhibitors in the absence of drug-selective pressure.	136
IL28B rs12979860 genotype as a predictor marker of progression to BKVirus Associated nephropathy, after kidney transplantation	136
Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL.	134
Infection and coinfection of human rhinovirus C in stem cell transplant recipients.	134
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy.	134
Revealing enterovirus infection in chronic human disorders: An integrated diagnostic approach	134
In vitro phenotypes to elvitegravir and dolutegravir in primary macrophages and lymphocytes of clonal recombinant viral variants selected in patients failing raltegravir	133
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts.	133
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression	130
Comparison of the artus HIV-1 QS-RGQ and VERSANT HIV-1 RNA 1.0 assays for quantitative detection of human immunodeficiency virus type 1 in plasma samples	128
Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family	126
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.	124
Rifabutin-based Helicobacter pylori eradication 'rescue therapy'.	124
The new and less toxic protease inhibitor saquinavir-NO maintains anti-HIV-1 properties in vitro indistinguishable from those of the parental compound saquinavir.	123
Characterization of GBV-C infection in HIV-1 infected patients.	122
Quantitative HIV-1 proviral DNA detection: a multicentre analysis.	121
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.	106
Phage display for the production of human monoclonal antibodies against human pathogens.	99
Humoral immune response against hepatitis C virus.	97
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).	93
Helicobacter pylori: a culprit in extraintestinal diseases?	91
Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.	90
Long-term study on symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients.	86
Phylogenetic internal control for HIV-1 genotypic antiretroviral testing.	86
Intra-host evolution of human immunodeficiency virus type 1 and viral fitness.	83
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group.	80
Targeting patients' microbiota with probiotics and natural fibers in adults and children with constipation	73
TMEM219 signaling promotes intestinal stem cell death and exacerbates colitis	50
Totale	10.230

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	40.064
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	40.064

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	823	0	0	0	0	0	130	83	111	175	45	103	176
2021/2022	655	81	141	5	53	8	21	41	42	33	82	66	82
2022/2023	990	79	6	48	114	111	245	1	135	184	26	14	27
2023/2024	1.794	311	330	304	338	353	83	5	13	36	4	0	17
2024/2025	701	1	1	151	5	6	77	65	18	25	54	64	234
2025/2026	956	187	133	96	248	211	81	0	0	0	0	0	0
Totale													10.230